These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12324171)

  • 1. Introduction to the supplemental issue on measurement and design issues in tobacco and drug use research.
    Clayton RR
    Drug Alcohol Depend; 2002 Nov; 68 Suppl 1():S3-5. PubMed ID: 12324171
    [No Abstract]   [Full Text] [Related]  

  • 2. Measurement and design issues in tobacco and drug use research.
    Collins LM; Flaherty BP; Colby SM
    Drug Alcohol Depend; 2002 Nov; 68 Suppl 1():S1-2. PubMed ID: 12324170
    [No Abstract]   [Full Text] [Related]  

  • 3. Conceptualizations of nicotine dependence: a response to DiFranza.
    Hughes JR; Shiffman S
    Nicotine Tob Res; 2008 Dec; 10(12):1811-2; author reply 1813-4. PubMed ID: 18989827
    [No Abstract]   [Full Text] [Related]  

  • 4. Time to re-examine old definitions of nicotine dependence.
    DiFranza JR; Riggs N; Ann Pentz M
    Nicotine Tob Res; 2008 Jun; 10(6):1109-11. PubMed ID: 18584475
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening patients for alcohol, tobacco, and other drug misuse: the role of brief interventions.
    Aristeiguieta CA
    West J Med; 2000 Jan; 172(1):53-7. PubMed ID: 10695447
    [No Abstract]   [Full Text] [Related]  

  • 6. [[DRG coding of drug addiction].
    de Zeeuw J; Baberg HT
    Med Klin (Munich); 2004 Aug; 99(8):482-3; discussion 483. PubMed ID: 15460611
    [No Abstract]   [Full Text] [Related]  

  • 7. Design of the NIDA clinical trials network validation study of tobacco, alcohol, prescription medications, and substance use/misuse (TAPS) tool.
    Wu LT; McNeely J; Subramaniam GA; Sharma G; VanVeldhuisen P; Schwartz RP
    Contemp Clin Trials; 2016 Sep; 50():90-7. PubMed ID: 27444426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New definition of addiction proposed by the American Society of Addiction Medicine: which implications for the treatment of tobacco dependence?
    Caraci F; Drago F
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):1-4. PubMed ID: 23778079
    [No Abstract]   [Full Text] [Related]  

  • 9. Substance use and diagnostic characteristics that differentiate smoking and nonsmoking adolescents in a psychiatric setting.
    Ramsey SE; Strong DR; Stuart GL; Weinstock MC; Williams LA; Tarnoff G; Picotte-Prillmayer DM; Brown RA
    J Nerv Ment Dis; 2003 Nov; 191(11):759-62. PubMed ID: 14614345
    [No Abstract]   [Full Text] [Related]  

  • 10. Exclusion criteria in treatment research on alcohol, tobacco and illicit drug use disorders: A review and critical analysis.
    Moberg CA; Humphreys K
    Drug Alcohol Rev; 2017 May; 36(3):378-388. PubMed ID: 27324921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sociocultural perspectives on substance abuse disorders.
    Walsh R
    Am J Psychiatry; 1992 Dec; 149(12):1760-1. PubMed ID: 1443269
    [No Abstract]   [Full Text] [Related]  

  • 12. The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-being.
    Degenhardt L; Hall W
    Nicotine Tob Res; 2001 Aug; 3(3):225-34. PubMed ID: 11506766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking and illicit drug use--a lesson yet to be learned.
    Stimmel B; Gold MS
    J Addict Dis; 1998; 17(1):1-5. PubMed ID: 9549598
    [No Abstract]   [Full Text] [Related]  

  • 14. American Academy of Pediatrics. Committee on Substance Abuse. Tobacco, alcohol, and other drugs: the role of the pediatrician in prevention and management of substance abuse.
    American Academy of Pediatrics. Committee on Substance Abuse
    Pediatrics; 1998 Jan; 101(1 Pt 1):125-8. PubMed ID: 11345974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The DSM-IV field trial for substance use disorders: major results.
    Cottler LB; Schuckit MA; Helzer JE; Crowley T; Woody G; Nathan P; Hughes J
    Drug Alcohol Depend; 1995 Apr; 38(1):59-69; discussion 71-83. PubMed ID: 7648998
    [No Abstract]   [Full Text] [Related]  

  • 16. An interpretative review of smokeless tobacco research in the United States: Part II.
    Glover ED; Schroeder KL; Henningfield JE; Severson HH; Christen AG
    J Drug Educ; 1989; 19(1):1-19. PubMed ID: 2656965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The disease of addiction: origins, treatment, and recovery.
    Angres DH; Bettinardi-Angres K
    Dis Mon; 2008 Oct; 54(10):696-721. PubMed ID: 18790142
    [No Abstract]   [Full Text] [Related]  

  • 18. Unhealthy drug use: how to screen, when to intervene.
    Zgierska A; Amaza IP; Brown RL; Mundt M; Fleming MF
    J Fam Pract; 2014 Sep; 63(9):524-30. PubMed ID: 25353031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-occurrence of tobacco product use, substance use, and mental health problems among adults: Findings from Wave 1 (2013-2014) of the Population Assessment of Tobacco and Health (PATH) Study.
    Conway KP; Green VR; Kasza KA; Silveira ML; Borek N; Kimmel HL; Sargent JD; Stanton C; Lambert E; Hilmi N; Reissig CJ; Jackson KJ; Tanski SE; Maklan D; Hyland AJ; Compton WM
    Drug Alcohol Depend; 2017 Aug; 177():104-111. PubMed ID: 28582698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisocial personality disorder, misbehavior, and drug abuse.
    Strain EC
    J Nerv Ment Dis; 1995 Mar; 183(3):162-5. PubMed ID: 7891062
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.